You are leaving Medscape Education
Cancel Continue
Log in to save activities Your saved activities will show here so that you can easily access them whenever you're ready. Log in here CME & Education Log in to keep track of your credits.
 

CPD

Vital Facts About Multi-Faceted GLP-1 RAs for the Cardiology Team: Short Questions -- Prompt Replies

  • Authors: Carol Wysham, MD; David Burnett, RN
  • CPD Released: 4/8/2022
  • Valid for credit through: 4/8/2023
Start Activity

  • Credits Available

    Non-US Physicians - maximum of 0.25 CPD

    You Are Eligible For

    • Letter of Completion

Target Audience and Goal Statement

This educational activity is intended for an international audience of non-US and non-UK cardiologists, nurses, diabetologists, and endocrinologists.

The goal of this activity is improve awareness about the cardiovascular benefits of newer glucose-lowering medications for patients with type 2 diabetes (T2D) at increased cardiovascular (CV) risk or with CV disease.

Upon completion of this activity, participants will:

  • Have increased knowledge regarding the
    • Multi-factorial benefits of newer glucose- lowering drugs like glucagon-like peptide-1 receptor agonists (GLP-1 RAs) with proven CV risk reduction
  • Have greater competence related to
    • The practical use of long-acting GLP-1 RAs in appropriate patients with T2D in cardiology care


Disclosures

WebMD Global requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. 

All relevant financial relationships for anyone with the ability to control the content of this educational activity are listed below and have been mitigated. Others involved in the planning of this activity have no relevant financial relationships with ineligible companies. 


Faculty

  • Carol Wysham, MD

    Clinical Professor of Medicine
    University of Washington
    Clinical Endocrinologist
    MultiCare/Rockwood Center for Diabetes and Endocrinology
    Spokane, Washington, United States

    Disclosures

    Disclosure: Carol Wysham, MD, has the following relevant financial relationships:
    Advisor or consultant for: Abbott
    Grants for clinical research from: Abbott; Corcept; Eli Lilly; Gilead; Milan; Novo Nordisk; Vanda Pharmaceuticals

  • David Burnett, RN

    Nurse Consultant in Cardiology
    University Hospitals Sussex NHS Foundation Trust
    West Sussex, United Kingdom

    Disclosures

    Disclosure: David Burnett, RN, has the following relevant financial relationships:
    Speaker or a member of a speakers bureau for: AstraZeneca

Editor

  • Walid Amara, MD

    Medical Education Director, WebMD Global, LLC

    Disclosures

    Disclosure: Walid Amara, MD, has no relevant financial relationships.

Compliance Reviewer

  • Susan L. Smith, MN, PhD

    Associate Director, Accreditation and Compliance

    Disclosures

    Disclosure: Susan L. Smith, MN, PhD, has no relevant financial relationships.

Peer Reviewer

This activity has been peer reviewed and the reviewer has no relevant financial relationships.


Accreditation Statements

Developed through a partnership between Medscape and British Association for Nursing in Cardiovascular Care (BANCC).

    For Physicians

  • The Faculty of Pharmaceutical Medicine of the Royal Colleges of Physicians of the United Kingdom (FPM) has reviewed and approved the content of this educational activity and allocated it 0.25 continuing professional development credits (CPD).

    Contact WebMD Global

For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]


Instructions for Participation and Credit

There are no fees for participating in or receiving credit for this online educational activity. For information about your eligibility to claim credit, please consult your professional licensing board.

This activity is designed to be completed within the time designated on the title page; physicians should claim only those credits that reflect the time actually spent participating in the activity. To successfully earn credit, participants must complete the activity online during the credit eligibility period that is noted on the title page.

Follow these steps to claim a credit certificate for completing this activity:

  1. Read the information provided on the title page regarding the target audience, learning objectives, and author disclosures, read and study the activity content and then complete the post-test questions. If you earn a passing score on the post-test and we have determined based on your registration profile that you may be eligible to claim CPD credit for completing this activity, we will issue you a CPD credit certificate.
  2. Once your CPD credit certificate has been issued, you may view and print the certificate from your CME/CE Tracker. CPD credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period you can print out the tally as well as the certificates by accessing "Edit Your Profile" at the top of the Medscape Education homepage.

We encourage you to complete an Activity Evaluation to provide feedback for future programming.

You may now view or print the certificate from your CME/CE Tracker. You may print the certificate but you cannot alter it. Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period you can print out the tally as well as the certificates by accessing "Edit Your Profile" at the top of your Medscape homepage.

*The credit that you receive is based on your user profile.

CPD

Vital Facts About Multi-Faceted GLP-1 RAs for the Cardiology Team: Short Questions -- Prompt Replies

Authors: Carol Wysham, MD; David Burnett, RNFaculty and Disclosures

CPD Released: 4/8/2022

Valid for credit through: 4/8/2023

processing....

Educational Impact Challenge

The goal of this activity is to have improved awareness about the CV benefits of newer glucose-lowering medications for patients with T2D at increased CV risk or with CVD.

Before you begin this activity, please assess your clinical knowledge by completing this brief survey. Answering these questions again after the activity will allow you to see what you learned and to compare your answers with those of your peers.

  • Print